These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6420511)

  • 1. Purification of the scrapie agent by density gradient centrifugation.
    Marsh RF; Dees C; Castle BE; Wade WF; German TL
    J Gen Virol; 1984 Feb; 65 ( Pt 2)():415-21. PubMed ID: 6420511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equilibrium density gradient centrifugation of the scrapie agent in Nycodenz.
    Marsh RF; Castle BE; Dees C; Wade WF
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():1963-8. PubMed ID: 6438273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of different methods of purification on aggregation of scrapie infectivity.
    Castle BE; Dees C; German TL; Marsh RF
    J Gen Virol; 1987 Jan; 68 ( Pt 1)():225-31. PubMed ID: 3100716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of proteins in membrane vesicles from scrapie-infected hamster brain.
    Dees C; German TL; Wade WF; Marsh RF
    J Gen Virol; 1985 Apr; 66 ( Pt 4)():851-9. PubMed ID: 3920349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of lipids in membrane vesicles from scrapie-infected hamster brain.
    Dees C; German TL; Wade WF; Marsh RF
    J Gen Virol; 1985 Apr; 66 ( Pt 4)():861-70. PubMed ID: 3920350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity.
    Riesner D; Kellings K; Post K; Wille H; Serban H; Groth D; Baldwin MA; Prusiner SB
    J Virol; 1996 Mar; 70(3):1714-22. PubMed ID: 8627692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis.
    McKinley MP; Meyer RK; Kenaga L; Rahbar F; Cotter R; Serban A; Prusiner SB
    J Virol; 1991 Mar; 65(3):1340-51. PubMed ID: 1704926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial purification of the scrapie agent from mouse brain by pressure disruption and zonal centrifugation in sucrose-sodium chloride gradients.
    Siakotos AN; Gajdusek DC; Gibbs CJ; Traub RD; Bucana C
    Virology; 1976 Mar; 70(1):230-7. PubMed ID: 816078
    [No Abstract]   [Full Text] [Related]  

  • 9. Properties of the scrapie agent-endomembrane complex from hamster brain.
    Semancik JS; Marsh RF; Geelen JL; Hanson RP
    J Virol; 1976 May; 18(2):693-700. PubMed ID: 131866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of scrapie agent from infected animal brains and raising of antibodies to the purified fraction.
    Takahashi K; Shinagawa M; Doi S; Sasaki S; Goto H; Sato G
    Microbiol Immunol; 1986; 30(2):123-31. PubMed ID: 3086675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent.
    Prusiner SB; Groth DF; Cochran SP; Masiarz FR; McKinley MP; Martinez HM
    Biochemistry; 1980 Oct; 19(21):4883-91. PubMed ID: 6775697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards purification of the scrapie agent.
    Diringer H; Hilmert H; Simon D; Werner E; Ehlers B
    Eur J Biochem; 1983 Aug; 134(3):555-60. PubMed ID: 6411468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characteristics of prion rods purified from scrapie-infected hamster brains.
    McKinley MP; Braunfeld MB; Bellinger CG; Prusiner SB
    J Infect Dis; 1986 Jul; 154(1):110-20. PubMed ID: 2872252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservation of infectivity in purified fibrillary extracts of scrapie-infected hamster brain after sequential enzymatic digestion or polyacrylamide gel electrophoresis.
    Brown P; Liberski PP; Wolff A; Gajdusek DC
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7240-4. PubMed ID: 2119503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial purification and evidence for multiple molecular forms of the scrapie agent.
    Prusiner SB; Hadlow WJ; Garfin DE; Cochran SP; Baringer JR; Race RE; Eklund CM
    Biochemistry; 1978 Nov; 17(23):4993-9. PubMed ID: 102338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and biochemical evidence that scrapie-associated fibrils assemble in vivo.
    Somerville RA; Ritchie LA; Gibson PH
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():25-35. PubMed ID: 2567338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical differences among scrapie-associated fibrils support the biological diversity of scrapie agents.
    Kascsak RJ; Rubenstein R; Merz PA; Carp RI; Wisniewski HM; Diringer H
    J Gen Virol; 1985 Aug; 66 ( Pt 8)():1715-22. PubMed ID: 3926951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoaffinity purification and neutralization of scrapie prions.
    Gabizon R; McKinley MP; Groth D; Westaway D; DeArmond SJ; Carlson GA; Prusiner SB
    Prog Clin Biol Res; 1989; 317():583-600. PubMed ID: 2574871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
    Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
    Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial copurification of scrapie-associated fibrils and scrapie infectivity.
    Somerville RA; Merz PA; Carp RI
    Intervirology; 1986; 25(1):48-55. PubMed ID: 2422138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.